|
|
Article: Boiron's 1st-half 2004 sales climb 5%.(Brief Article)
- Article from:
- Nutraceuticals International
- Article date:
- August 1, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Boiron, a leading French producer of homeopathic drugs, saw its first-half 2004 sales climb 5% to 149.1 million euros ($173.3 million).
Revenues were driven by 10% growth in international markets to 49 million euros and a 3% rise in domestic turnover to 100.1 million euros. International sales were led by a 15% increase in US turnover to 12 million euros. Revenue trends by speciality show growth in the family medication sector and in generic homeopathic drugs, of 8.6% and 2.3%, respectively, Boiron said.
The company turned in solid results for the period in spite of the current difficult ...